BIAF
BIAF
NASDAQ · Biotechnology

Bioaffinity Technologies Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$3.87
+0.33 (+9.32%)
As of Mar 31, 5:00 PM ET ·
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +633.6% upside
Low Target $22.24
Average Target $28.39
High Target $33.42
Current Price $3.87
Current
$3.87
Target
$28.39
$22.24 $28.39 avg $33.42
Scenario Analysis
Bear Case
$22.24
474.7%
Low target
Base Case
$28.39
+633.6%
Avg target
Bull Case
$33.42
+763.6%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$46.53
-91.7% from high
52-Week Low
$0.69
+458.4% from low
Target vs 52W High
$28.39
-39.0% vs high
Next Earnings Report
Apr 6, 2026
4d
until earnings
EPS Est: $-2.75
Earnings in 4 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 69% $257.58 +18.4%
AMGN
Amgen Inc
 Hold 42 50% $190.87 -45.8%
GILD
Gilead Sciences Inc
 Strong Buy 38 79% $362.68 +160.2%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 -1.8%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 78% $102.31 -69.1%
INSM
Insmed Inc
 Strong Buy 26 92% $143.40 -12.3%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -28.5%